Risk of second primary malignancies in head and neck cancer patients treated with definitive radiotherapy

Second primary malignancy (SPM) may occur after index head and neck cancer (HNC) treatment. This study evaluated the prevalence and outcome of SPM in patients with HNC treated with definitive radiotherapy. Eligible patients include those with index mucosal HNC treated with definitive radiotherapy be...

Descripción completa

Detalles Bibliográficos
Autores principales: Ng, Sweet Ping, Pollard, Courtney, Kamal, Mona, Ayoub, Zeina, Garden, Adam S., Bahig, Houda, Gunn, G. Brandon, Frank, Steven J., Skinner, Heath D., Phan, Jack, Berends, Joel, Morrison, William H., Johnson, Jason M., Ferrarotto, Renata, Sturgis, Erich M., Mohamed, Abdallah S. R., Lai, Stephen Y., Fuller, Clifton D., Rosenthal, David I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764977/
https://www.ncbi.nlm.nih.gov/pubmed/31583278
http://dx.doi.org/10.1038/s41698-019-0097-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764977/
https://www.ncbi.nlm.nih.gov/pubmed/31583278
http://dx.doi.org/10.1038/s41698-019-0097-y

Ejemplares similares